Brief: Genmab: Completion Of Tender Offer For Outstanding Common Shares Of Merus N.V.

Genmab A/S

12/12/2025 06:47

Dec 12 (Reuters) - Genmab A/S GMAB.CO:

GENMAB ANNOUNCES COMPLETION OF TENDER OFFER FOR OUTSTANDING COMMON SHARES OF MERUS N.V. AND COMMENCEMENT OF SUBSEQUENT OFFERING PERIOD

EXPECTS TO LAUNCH PETOSEMTAMAB IN 2027

INTENDS TO BROADEN AND ACCELERATE PETOSEMTAMAB'S DEVELOPMENT WITH POTENTIAL EXPANSION INTO OTHER LINES OF THERAPY

BELIEVES THAT PETOSEMTAMAB WILL BE ACCRETIVE TO EBITDA WITH AT LEAST ONE-BILLION-DOLLAR ANNUAL SALES POTENTIAL BY 2029

94.2% OF MERUS SHARES TENDERED IN GENMAB'S OFFER

Source text: ID:nGNE1tXd77

Further company coverage: GMAB.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))